Comparison of Two Different Treat-and-Extend Protocols with Aflibercept in Wet Age-Related Macular Degeneration: Two-Year Results
ConclusionsAt 2 years, the anatomical and functional responses between the two treatment groups were similar. However, the number of given aflibercept injections was smaller in the rapid extensions protocol.Trial RegistrationEU Clinical Trials Register Number, 2015-001394-41/FI
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Clinical Trials | Drugs & Pharmacology | Eyes | Study